Concepedia

Publication | Closed Access

A pilot phase 2 study of oregovomab murine monoclonal antibody to CA125 as an immunotherapeutic agent for recurrent ovarian cancer

DOI

81

Citations

24

References

2005

Year

Tom Ehlen, P. Hoskins, David F. Miller, T L Whiteside, Christopher F. Nicodemus, Birgit C. Schultes, K. Swenerton
International Journal of Gynecological Cancer

References

YearCitations

Page 1